<SEC-DOCUMENT>0001520138-25-000243.txt : 20250807
<SEC-HEADER>0001520138-25-000243.hdr.sgml : 20250807
<ACCEPTANCE-DATETIME>20250806201150
ACCESSION NUMBER:		0001520138-25-000243
CONFORMED SUBMISSION TYPE:	8-A12B
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250807
DATE AS OF CHANGE:		20250806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOVIE INC.
		CENTRAL INDEX KEY:			0001580149
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				462510769
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-A12B
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39015
		FILM NUMBER:		251191188

	BUSINESS ADDRESS:	
		STREET 1:		680 W NYE LANE
		STREET 2:		SUITE 201
		CITY:			CARSON CITY
		STATE:			NV
		ZIP:			89703
		BUSINESS PHONE:		775-888-3162

	MAIL ADDRESS:	
		STREET 1:		680 W NYE LANE
		STREET 2:		SUITE 201
		CITY:			CARSON CITY
		STATE:			NV
		ZIP:			89703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NANOANTIBIOTICS, INC.
		DATE OF NAME CHANGE:	20130625
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-A12B
<SEQUENCE>1
<FILENAME>bivi-8a12b.htm
<DESCRIPTION>FORM 8-A12B
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<Center><DIV STYLE="width:8.5in" align="left">

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
WASHINGTON, DC 20549</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>FORM 8-A</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES<BR>
PURSUANT TO SECTION 12(b) OR 12(g) OF THE<BR>
SECURITIES EXCHANGE ACT OF 1934</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 20%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 60%; padding: 0.25pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>BIOVIE INC.</U></P></TD>
    <TD STYLE="vertical-align: bottom; width: 20%; padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt">(Exact name of registrant as specified in its charter)</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 40%; padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt"><U>Nevada</U></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 20%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 40%; padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt"><U>46-2510769</U></FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt">(State or other jurisdiction of incorporation</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt">(I.R.S. Employer</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt">or organization)</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt">Identification No.)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt"><U>680 W Nye Lane Suite 201</U></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt"><U>Carson City, Nevada</U></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt"><U>89703</U></FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 11pt">(Zip Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Securities to be registered pursuant to Section 12(b) of the Act:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 40%; padding: 0.25pt 5.65pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; border-bottom: black 0.5pt solid">Title of each class to be registered</P></TD>
    <TD STYLE="width: 60%; padding: 0.25pt 5.65pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; border-bottom: black 0.5pt solid">Name of each exchange on which
    each class is to be registered</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 12.25pt 5.65pt 0.25pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Warrants to purchase Class A common Stock, par value $.0001 per share</FONT></TD>
    <TD STYLE="padding: 12.25pt 5.65pt 0.25pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">The NASDAQ Stock Market, LLC</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 11pt">If this form relates to the registration
of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e),
please check the following box. </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9746;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 11pt">If this form relates to the registration
of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e),
please check the following box. </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><FONT STYLE="font-size: 11pt">If this form relates to the registration
of a class of securities concurrently with a Regulation A offering, check the following box. </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">Securities Act registration statement number or Regulation A offering
statement number to which this form relates: <U>333-288525</U> (if applicable)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt">Securities to be registered pursuant to Section 12(g) of the Act:
None.&nbsp;</P>

</div></center>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1.5pt solid; width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding: 0.25pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt"><B>Item 1.</B></FONT></TD>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt"><B>Description of Registrant's Securities to be Registered.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0">This registration statement relates to the registration with the Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) of warrants to purchase shares of shares of Class A common stock, par value $0.0001 per share
(the &ldquo;Warrants&rdquo;), of BioVie Inc. (the &ldquo;Registrant&rdquo;). The description of the Warrants being registered pursuant
to this Form 8-A that is set forth under the heading &ldquo;Description of Securities&rdquo; in the prospectus contained in the Registrant&rsquo;s
Registration Statement on Form S-1 (Registration No. 333-288525), as initially filed with the Commission on July 3, 2025 and as subsequently
amended (the &ldquo;Registration Statement&rdquo;), is incorporated by reference into this Form 8-A. Any form of prospectus or prospectus
supplement to the Registration Statement that includes such descriptions and that are subsequently filed are hereby also incorporated
by reference herein.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>


 <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding: 0.25pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt"><B>Item 2.</B></FONT></TD>
    <TD STYLE="padding: 0.25pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt"><B>Exhibits</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the instructions as to Exhibits of Form 8-A, the following
have been filed as exhibits to the Registration Statement and are incorporated herein by reference:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0">&nbsp;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: middle">
    <TD STYLE="border-bottom: black 1pt solid; text-align: left; font-weight: bold; width: 5%; vertical-align: bottom">Exhibit No.</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; font-weight: bold; border-bottom: black 1pt solid; width: 93%; vertical-align: bottom">Description</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; border-top-color: black; border-top-width: 1pt; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000154823313000011/nano0813ex-3.1.htm" STYLE="-sec-extract: exhibit">3.1</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-top-color: black; border-top-width: 1pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000154823313000011/nano0813ex-3.1.htm" STYLE="-sec-extract: exhibit">Articles of Incorporation of the Company as filed with the Secretary of State of Nevada (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Registration Statement on Form S-1 filed on August 15, 2013, File No. 333-190635).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013816001063/nnab-20160722_8kex3z1.htm" STYLE="-sec-extract: exhibit">3.2</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013816001063/nnab-20160722_8kex3z1.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K filed on July 22, 2016).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013818000151/bivi-20180713_def14c.htm" STYLE="-sec-extract: exhibit">3.3</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013818000151/bivi-20180713_def14c.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment to Articles of Incorporation (incorporated by reference to Appendix A to the Company&rsquo;s Information Statement on Schedule 14C filed on July 13, 2018).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013818000134/biovie-20180703_8kex3z1.htm" STYLE="-sec-extract: exhibit">3.4</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013818000134/biovie-20180703_8kex3z1.htm" STYLE="-sec-extract: exhibit">Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K filed on July 3, 2018).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013819000485/bivi-20191122_s1a8ex3z6.htm" STYLE="-sec-extract: exhibit">3.5</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013819000485/bivi-20191122_s1a8ex3z6.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.6 to the Company&rsquo;s Registration Statement on Form S-1 filed on November 22, 2019, File No. 333-231136).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013821000706/bivi-20210930_10qex3z5.htm" STYLE="-sec-extract: exhibit">3.6</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013821000706/bivi-20210930_10qex3z5.htm" STYLE="-sec-extract: exhibit">Amended and Restated Bylaws of the Company, dated June 16, 2020 (incorporated by reference to Exhibit 3.5 to the Company&rsquo;s Quarterly Report on Form 10-Q filed on November 10, 2021).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013823000131/bivi-20230313_8kex3z1.htm" STYLE="-sec-extract: exhibit">3.7</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013823000131/bivi-20230313_8kex3z1.htm" STYLE="-sec-extract: exhibit">First Amendment to the Amended and Restated Bylaws of the Company, dated March 12, 2023 (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K filed on March 13, 2023).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013824000254/bivi-20240729_8kex3z1.htm" STYLE="-sec-extract: exhibit">3.8</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013824000254/bivi-20240729_8kex3z1.htm" STYLE="-sec-extract: exhibit">Certificate of Change (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Current Report on Form 8-K filed on August 1, 2024)</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013824000263/bivi-20240802_8kex3z1.htm" STYLE="-sec-extract: exhibit">3.9</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013824000263/bivi-20240802_8kex3z1.htm" STYLE="-sec-extract: exhibit">Termination of Amendment/Certificate (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Current Report, as amended, on Form 8-K/A filed on August 6, 2024).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right; width: 5%"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013824000263/bivi-20240802_8kex3z2.htm" STYLE="-sec-extract: exhibit">3.10</A></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 93%"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013824000263/bivi-20240802_8kex3z2.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment (incorporated by reference to Exhibit 3.2 to the Company&rsquo;s Current Report, as amended, on Form 8-K/A filed on August 6, 2024).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013819000127/bivi-20190426_s1ex4z1.htm" STYLE="-sec-extract: exhibit">4.1</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013819000127/bivi-20190426_s1ex4z1.htm" STYLE="-sec-extract: exhibit">Specimen Certificate representing shares of Class A Common Stock (incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Registration Statement on Form S-1 filed on April 26, 2019, File No. 333-231136).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013819000330/bivi-20190924_8kex4z2.htm" STYLE="-sec-extract: exhibit">4.2</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013819000330/bivi-20190924_8kex4z2.htm" STYLE="-sec-extract: exhibit">Form of Warrant (incorporated by reference to Exhibit 4.2 to the Company&rsquo;s Current Report on Form 8-K filed on September 25, 2019).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013819000330/bivi-20190924_8kex4z2.htm" STYLE="-sec-extract: exhibit">4.3</A></TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013819000330/bivi-20190924_8kex4z2.htm" STYLE="-sec-extract: exhibit">Form of Warrant (incorporated by reference to Exhibit 4.2 to the Company&rsquo;s Current Report&nbsp;on Form 8-K filed on September 25, 2019).</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: right"></TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-align: right; vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013819000330/bivi-20190924_8kex4z1.htm" STYLE="-sec-extract: exhibit">4.4</A></TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013819000330/bivi-20190924_8kex4z1.htm" STYLE="-sec-extract: exhibit">Form of 10% OID Convertible Delayed Draw Debenture (incorporated by reference to Exhibit 4.1 the Company&rsquo;s Current Report on Form 8-K filed on September 25, 2019).</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: right"></TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-align: right; vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013822000313/bivi-20220715_8ka1ex4z1.htm" STYLE="-sec-extract: exhibit">4.5</A></TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013822000313/bivi-20220715_8ka1ex4z1.htm" STYLE="-sec-extract: exhibit">Form of Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K/A filed on July 18, 2022).</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013821000754/bivi-20211130_8kex10z3.htm" STYLE="-sec-extract: exhibit">4.6</A></TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013821000754/bivi-20211130_8kex10z3.htm" STYLE="-sec-extract: exhibit">Form of Warrant to Purchase Shares of Class A Common Stock of the Company (incorporated by reference to Exhibit 10.3 to the Company&rsquo;s Current Report on Form 8-K filed on December 1, 2021).</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013824000086/bivi-20240304_8kex4z2.htm" STYLE="-sec-extract: exhibit">4.7</A></TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013824000086/bivi-20240304_8kex4z2.htm" STYLE="-sec-extract: exhibit">Form of Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.2 to the Company&rsquo;s Current Report on Form 8-K filed on March 4, 2024).</A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013824000086/bivi-20240304_8kex10z1.htm" STYLE="-sec-extract: exhibit">4.8</A></TD>
    <TD STYLE="font-family: Aptos Narrow; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013824000086/bivi-20240304_8kex10z1.htm" STYLE="-sec-extract: exhibit">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.3 to the Company&rsquo;s Current Report on Form 8-K filed on March 4, 2024).</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013825000198/bivi_s1ex4z18.htm" STYLE="-sec-extract: exhibit">4.9</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013825000198/bivi_s1ex4z18.htm" STYLE="-sec-extract: exhibit">Form of Warrant (incorporated by reference to Exhibit 4.18 to the Company&rsquo;s Registration Statement on Form S-1 filed on July 3, 2025)</A></TD></TR>
  <TR STYLE="vertical-align: middle; background-color: White">
    <TD STYLE="text-align: right; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: middle; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013825000198/bivi_s1ex4z20.htm" STYLE="-sec-extract: exhibit">10.1</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1580149/000152013825000198/bivi_s1ex4z20.htm" STYLE="-sec-extract: exhibit">Form of Warrant Agent Agreement (incorporated by reference to Exhibit 4.20 to the Company&rsquo;s Registration Statement on Form S-1 filed on July 3, 2025)</A></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereto duly authorized.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt 5.65pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt 5.65pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">BIOVIE INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt 5.65pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt 5.65pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt 5.65pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt 5.65pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt 5.65pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt 5.65pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt 5.65pt; font: 12pt Times New Roman, Times, Serif">Date: August 6, 2025 </TD>
    <TD STYLE="padding: 0.25pt 5.65pt; font: 12pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding: 0.25pt 5.65pt 0.5pt"><FONT STYLE="font-size: 11pt"><I>/s/ Joanne Wendy Kim</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt 5.65pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt 5.65pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Name: Joanne Wendy Kim</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt 5.65pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt 5.65pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 11pt">Title: Chief Financial Officer</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 52%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 5%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 43%; padding: 0.25pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
